Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer

被引：0
|
作者：
Matti S. Aapro
Stephen Chaplin
Paul Cornes
Sebastian Howe
Hartmut Link
Natalia Koptelova
Andrea Mehl
Mario Di Palma
Bridgette Kanz Schroader
Robert Terkola
机构：
[1] Genolier Cancer Center,Gustave Roussy
[2] Xcenda UK,undefined
[3] Comparative Outcomes Group,undefined
[4] Sandoz International GmbH,undefined
[5] Private Practice Hematology Oncology Kaiserslautern,undefined
[6] Paris-Saclay University,undefined
[7] Xcenda LLC,undefined
[8] a Cencora company,undefined
[9] University Medical Center,undefined
[10] Paracelsus Medical University,undefined
来源：
Supportive Care in Cancer | 2023年 / 31卷
关键词：
Febrile neutropenia; Cost-effectiveness; Filgrastim; Biosimilar; Pegfilgrastim;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients
    Renner, Peter
    Milazzo, Stefania
    Liu, Jian Ping
    Zwahlen, Marcel
    Birkmann, Josef
    Horneber, Markus
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10):
  • [32] Granulocyte-macrophage colony-stimulating factor in established febrile neutropenia
    Mitchell, PLR
    Pinkerton, CR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3002 - 3002
  • [33] Granulocyte colony-stimulating factor in established febrile neutropenia: A randomized study of pediatric patients
    Mitchell, PLR
    Morland, B
    Stevens, MCG
    Dick, G
    Easlea, D
    Meyer, LC
    Pinkerton, CR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1163 - 1170
  • [34] Colony-Stimulating Factors for the Management of Neutropenia in Cancer Patients
    David C. Dale
    [J]. Drugs, 2002, 62 : 1 - 15
  • [35] Colony-stimulating factors for the management of neutropenia in cancer patients
    Dale, DC
    [J]. DRUGS, 2002, 62 (Suppl 1) : 1 - 15
  • [36] Cost effectiveness of pegfilgrastim vs filgrastim for febrile neutropenia(FN) prevention in breast cancer patients
    Danova, M.
    Rosti, G.
    Dubois, R. W.
    Chiroli, S.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 38 - 38
  • [37] Colony-stimulating factors (CSFs) for established febrile neutropenia (FN) revisited: An economic analysis based on a meta-analysis of randomized controlled trials (RCTs).
    Lyman, GH
    Djulbegovic, B
    Kuderer, NM
    Dale, D
    [J]. BLOOD, 2002, 100 (11) : 502B - 502B
  • [38] COMPARATIVE EFFECTIVENESS OF GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF) FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA (FN) -RELATED HOSPITALIZATION: A RETROSPECTIVE COHORT STUDY USING GERMAN CLAIMS DATA
    Wetten, S.
    Li, X.
    Haas, J.
    Worth, G.
    Jacob, C.
    Braun, S.
    Tzivelekis, S.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A434 - A434
  • [39] Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia
    Lee, Jin A.
    Sauer, Brooke
    Tuminski, William
    Cheong, Jiyu
    Fitz-Henley, John, II
    Mayers, Megan
    Ezuma-Igwe, Chidera
    Arnold, Christopher
    Hornik, Christoph R.
    Clark, Reese H.
    Benjamin, Daniel K., Jr.
    Smith, P. Brian
    Ericson, Jessica E.
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2017, 34 (05) : 458 - 464
  • [40] Granulocyte colony-stimulating factor in afebrile patients with neutropenia
    Cabanillas, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18): : 1319 - 1319
12345